Gibson Dunn, Freshfields, Gilbert + Tobin and Homburger have advised SpaceX. Davis Polk, Lenz & Staehelin and Mallesons have advised the global underwriting syndicate, including all...
SpaceX Raises $75 Billion in Landmark Initial Public Offering
SpaceX Secures Strategic AI Partnership with Cursor and $60 Billion Option to Acquire
Gibson Dunn has advised SpaceX. SpaceX has announced a significant partnership with Cursor to develop a next-generation artificial intelligence platform focused on coding and knowledge work,...
Jade Biosciences’ Merger with Aerovate Therapeutics
Gibson, Dunn & Crutcher advised Jade Biosciences on the transaction, and Cooley advised the placement agents; while Goodwin Procter advised Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc....
GlycoMimetics’ Acquisition of Crescent Biopharma
Sidley Austin is advising GlycoMimetics, Inc. on the transaction, and Gibson, Dunn & Crutcher is advising Crescent Biopharma, Inc. GlycoMimetics, Inc. (NASDAQ: GLYC) announced it has...
ARCA Biopharma’s Merger with Oruka Therapeutics
Wilson Sonsini Goodrich & Rosati is advising ARCA biopharma, Inc. on the transaction, while Gibson, Dunn & Crutcher is advising Oruka Therapeutics and Cooley is advising...
Pathos AI’s Acquisition of Rain Oncology
Leerink Partners is acting as exclusive financial advisor and Gibson, Dunn & Crutcher LLP is acting as legal counsel to Rain. Goodwin Procter LLP is acting...
Essential AI’s $56.5 Million Capital Raise
Gibson, Dunn & Crutcher LLP advised Essential AI on the capital raise. Essential AI has raised a $56.5 million Series A funding round led by March...
Electriq Power’s Merger with TLG Acquisition One Corp.
Ellenoff Grossman & Schole LLP acted as legal counsel to Electriq Power, and Gibson, Dunn & Crutcher LLP acted as legal counsel to TLG Acquisition One...
Aeglea’s Acquisition of Spyre
Gibson, Dunn & Crutcher LLP is advising Spyre Therapeutics, Inc. in the transaction, while Cooley LLPis advising Aeglea. Aeglea BioTherapeutics, Inc. (“Aeglea”) (NASDAQ: AGLE), announced it has completed...
Magenta Therapeutics’ Merger with Dianthus Therapeutics
Gibson, Dunn & Crutcher LLP acted for Dianthus Therapeutics, Inc. on its merger with Magenta Therapeutics, Inc., assisted by Goodwin Procter. Magenta Therapeutics, Inc. (Nasdaq: MGTA) and Dianthus Therapeutics,...
Charlesbank Capital Partners and Motive Partners’ Investment in Accordion Partners
Willkie Farr & Gallagher advised FFL Partners and Accordion, while Ropes & Gray advised Charlesbank and Gibson, Dunn & Crutcher advised Motive on the deal. FFL...
NetApp’s Acquisition of Data Mechanics
IN BRIEF: Gibson Dunn & Crutcher, IC Avocats, Peltier Juvigny Marpeau & Associés, advised on the matter. Gibson Dunn & Crutcher advised NetApp with a team...